CIK 0000887359 · Large accelerated filer
Vericel Corp
Sign in to watch- Ticker
- VCEL
- Exchange
- Nasdaq
- Industry
- Biological Products, (No Diagnostic Substances)
- FY end
- Dec 31
- Incorporated
- MI
- Entity type
- operating
- EIN
- 943096597
- Phone
- 6175885555
- Business address
- 25 BLUE SKY DRIVE, BURLINGTON, MA, 01803
- Former names
- AASTROM BIOSCIENCES INC
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $5,787,802
- in 7 filings, $5.8M under 10b5-1 plans
Net −$5,787,802. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
- Mara Joseph Anthony Jr −$4.1M Chief Financial Officer sold 82% of stake
- Flynn Sean C. −$779K Chief Legal Officer sold 88% of stake
- MCLAUGHLIN KEVIN F −$413K Director sold 28% of stake
- ZERBE ROBERT L MD −$386K Director sold 19% of stake
- SIEGAL JONATHAN −$79K Principal Accounting Officer sold 54% of stake
Reading 65 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2021-07-21 | Flynn Sean C. VP, General Counsel | Option exercise · Stock Option (right to buy) | −2,800 | 137,200 | ||
| 2021-07-15 | Flynn Sean C. VP, General Counsel | Option exercise | +10,000 | $16.25 | $163K | 12,419 |
| 2021-07-15 | Flynn Sean C. VP, General Counsel | Sale | −10,000 | $51.18 | $512K | 2,419 |
| 2021-07-15 | Flynn Sean C. VP, General Counsel | Option exercise · Stock Option (right to buy) | −10,000 | 140,000 | ||
| 2021-07-12 | Halpin Michael Chief Operating Officer | Option exercise | +20,000 | $2.65 | $53K | 25,623 |
| 2021-07-12 | Halpin Michael Chief Operating Officer | Sale | −20,000 | $53.54 | $1.1M | 5,623 |
| 2021-07-12 | Halpin Michael Chief Operating Officer | Option exercise · Stock Option (right to buy) | −20,000 | 27,063 | ||
| 2021-06-30 | Hopper Jonathan Mark Chief Medical Officer | Option exercise | +694 | $10.95 | $8K | 39,453 |
| 2021-06-30 | Hopper Jonathan Mark Chief Medical Officer | Sale | −134 | $57.14 | $8K | 39,319 |
| 2021-06-30 | Hopper Jonathan Mark Chief Medical Officer | Option exercise · Stock Option (right to buy) | −694 | 57,604 | ||
| 2021-06-30 | Mara Joseph Anthony Jr Chief Financial Officer | Option exercise | +4,000 | 7,022 | ||
| 2021-06-30 | Mara Joseph Anthony Jr Chief Financial Officer | Shares withheld for taxes | −1,174 | $52.50 | $62K | 5,848 |
| 2021-06-30 | Mara Joseph Anthony Jr Chief Financial Officer | Option exercise · Restricted Stock Unit | −4,000 | $52.50 | $210K | 8,000 |
| 2021-06-01 | WRIGHT LISA Director | Grant or award · Restricted Stock Unit | +1,300 | 1,300 | ||
| 2021-06-01 | WRIGHT LISA Director | Grant or award · Stock Option (right to buy) | +3,250 | 3,250 | ||
| 2021-06-01 | WRIGHT LISA Director | Grant or award · Stock Option (right to buy) | +5,877 | 5,877 | ||
| 2021-06-01 | WRIGHT LISA Director | Grant or award · Restricted Stock Unit | +2,351 | 2,351 | ||
| 2021-05-19 | Hagen Heidi Director | Option exercise | +1,500 | $6.00 | $9K | 5,000 |
| 2021-05-19 | Hagen Heidi Director | Option exercise | +3,000 | $4.12 | $12K | 8,000 |
| 2021-05-19 | Hagen Heidi Director | Option exercise | +2,250 | $6.00 | $14K | 10,250 |
Page 47 of 75 · 1,497 trades